Holen Sie sich die Stockscreener-App
396.75
3.09%
-12.67
Handel nachbörslich:
399.00
2.25
+0.57%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HUM?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$409.42
Offen:
$412.22
24-Stunden-Volumen:
1.39M
Relative Volume:
0.82
Marktkapitalisierung:
$47.63B
Einnahmen:
$137.20B
Nettoeinkommen (Verlust:
$1.15B
KGV:
42.46
EPS:
9.3439
Netto-Cashflow:
$1.27B
1W Leistung:
+5.52%
1M Leistung:
+23.64%
6M Leistung:
+50.01%
1J Leistung:
+62.74%
1-Tages-Spanne:
$391.64
$415.00
1-Wochen-Bereich:
$372.61
$415.00
52-Wochen-Spanne:
$163.11
$415.00
Humana Inc Stock (HUM) Company Profile
Firmenname
Humana Inc
Sektor
Branche
Telefon
(502) 580-1000
Adresse
101 E. MAIN STREET, LOUISVILLE, KY
Compare HUM vs UNH, CVS, ELV, CI
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
396.75 | 47.69B | 137.20B | 1.15B | 1.27B | 9.3439 |
UNH
Unitedhealth Group Inc
|
425.36 | 377.45B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
104.72 | 131.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
417.89 | 83.98B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
287.77 | 72.93B | 278.13B | 6.74B | 7.66B | 23.60 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-02-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2026-01-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-12-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-10-14 | Eingeleitet | Goldman | Sell |
| 2025-09-22 | Eingeleitet | Evercore ISI | In-line |
| 2025-05-01 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-11-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | Herabstufung | Jefferies | Buy → Hold |
| 2024-10-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-10-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-10-02 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-03-22 | Eingeleitet | Raymond James | Mkt Perform |
| 2024-03-13 | Herabstufung | Argus | Buy → Hold |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-12 | Hochstufung | Argus | Hold → Buy |
| 2023-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-07-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-06-23 | Herabstufung | Argus | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-10-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-09-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-04-13 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-04 | Bestätigt | Barclays | Overweight |
| 2021-11-04 | Bestätigt | Credit Suisse | Outperform |
| 2021-11-04 | Bestätigt | Morgan Stanley | Overweight |
| 2021-11-04 | Bestätigt | Oppenheimer | Outperform |
| 2021-11-04 | Bestätigt | RBC Capital Mkts | Outperform |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-09-09 | Fortgesetzt | Barclays | Overweight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Neutral |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-01-04 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-16 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-06-05 | Eingeleitet | Goldman | Buy |
| 2020-01-03 | Bestätigt | JP Morgan | Overweight |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | Eingeleitet | UBS | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-08 | Bestätigt | BofA/Merrill | Buy |
| 2018-09-13 | Eingeleitet | Barclays | Overweight |
| 2018-07-12 | Fortgesetzt | Morgan Stanley | Overweight |
| 2018-07-06 | Bestätigt | Piper Jaffray | Overweight |
| 2018-06-01 | Fortgesetzt | Citigroup | Buy |
| 2018-02-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | Bestätigt | Leerink Partners | Outperform |
| 2018-01-12 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Humana Inc Aktie (HUM) Neueste Nachrichten
Humana Inc (HUM) Shares Surge 3.1% -- What GF Score of 87 Tells Investors - GuruFocus
Humana, Centene lead healthcare rally in Q2 over Medicare Advantage optimism - Seeking Alpha
The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants - Business Wire
How CenterWell Is Driving Humana's Growth Beyond Insurance - Zacks Investment Research
2026-06-28 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Humana Inc. (HUM) and Encourages Shareholders to Learn More About the Investigation | NYSE:HUM | Press Release - Stockhouse
Humana Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Humana Inc. Actuals & Estimates (MUN:HUM) - TradingView
Humana stock hits 52-week high at 381.2 USD By Investing.com - Investing.com Nigeria
Humana stock hits 52-week high at 381.2 USD - Investing.com
Humana Inc. Actuals & Estimates (BMV:HUM) - TradingView
Humana Inc. (HUM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Humana Inc. Actuals & Estimates (XETR:HUM) - TradingView
Humana Inc. Actuals & Estimates (BIVA:HUM) - TradingView
Humana Inc.: - marketscreener.com
A Look at Humana Inc (HUM) After 4.0% Gain -- GF Value $362.88 v - GuruFocus
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
Health Insurance Providers Stocks Q1 Results: Benchmarking Humana (NYSE:HUM) - Yahoo Finance
Price to sales forward of Humana Inc. – NYSE:HUM - TradingView
Humana Inc. $HUM Shares Sold by Leeward Investments LLC MA - MarketBeat
Price to earnings forward of Humana Inc. – NYSE:HUM - TradingView
Did Humana’s (HUM) Illinois Medicaid Win and MA Uncertainty Just Rebalance Its Risk Profile? - simplywall.st
UnitedHealth, Humana and CVS denied post-hospital care at some of the highest rates - Medical Xpress
Can Humana's Margin Recovery Drive Long-Term Earnings Growth? - The Globe and Mail
UnitedHealth, Humana And CVS Denied Post-Hospital Care At Some Of The Highest Rates - U.S. News & World Report
HUM News | HUMANA INC (NYSE:HUM) - ChartMill
Humana Inc. Stock 12‑Month Price Target Raised to $301.12, Implies 16% Downside - TradingView
Humana Inc. (HUM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Humana Inc. (NYSE: HUM) Investor Alert - marketscreener.com
Here’s What Hit Humana (HUM) in Q1 - Insider Monkey
symbol__ Stock Quote Price and Forecast - CNN
Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026 - Humana
Humana Inc. (NYSE: HUM) Investor Alert: Possible False Statements and Insider Sales - Schubert Jonckheer & Kolbe
Deals tracker: Hackensack Meridian Health explores merger - Modern Healthcare
UnitedHealth vs. Humana: Which Healthcare Leader Is a Better Bet Now? - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Is Investigating Humana Inc. (HUM) And Encourages Investors to Connect - ACCESS Newswire
UnitedHealth (UNH) Joins Optura As Former Humana And CVS Chiefs Sign On - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages Humana Inc. (HUM) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound - Investing.com
Humana says will not bid for Centene Corp - Yahoo Finance
Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State - Humana
Humana Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Humana (HUM) Chosen for HealthChoice Illinois Medicaid Program - GuruFocus
Humana wins Illinois Medicaid contract for statewide coverage - Investing.com
Humana wins Illinois Medicaid contract for statewide coverage By Investing.com - Investing.com Canada
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Humana Inc. (HUM) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Humana Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Humana, CenterWell and National Hispanic Medical Association Announce 2026 Resident Physician Scholarship Program Recipients - Business Wire
Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc.HUM - Business Wire
Humana employees donate $1.4M - The Business Journals
UBS reiterates Humana stock rating on utilization trends By Investing.com - Investing.com Canada
UBS reiterates Humana stock rating on utilization trends - Investing.com
Finanzdaten der Humana Inc-Aktie (HUM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
3.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):